Iqvia Holdings (IQV) Net Cash Flow Growth (1y) (2013 - 2026)
Iqvia Holdings (IQV) Net Cash Flow Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 214.22 Bn | 210.16 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 140.38 Bn | 136.03 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.80 Bn | 37.99 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 39.51 Bn | 37.43 Bn | 1.44 Bn | -115.29% |
| 6 | Natera | 38.83 Bn | 37.73 Bn | 696.04 Mn | -58.16% |
| 7 | Illumina | 30.02 Bn | 28.85 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.64 Bn | 28.59 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.54 Bn | 1.03 Bn | 84.25% |
| 10 | Labcorp Holdings | 25.90 Bn | 24.92 Bn | 1.01 Bn | 138.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -115.29% |
| Mar 31, 2026 | -320.00% |
| Dec 31, 2025 | -17.00% |
| Sep 30, 2025 | -1,326.67% |
| Jun 30, 2025 | 126.17% |
| Mar 31, 2025 | -95.10% |
| Dec 31, 2024 | 73.91% |
| Sep 30, 2024 | 88.81% |
| Jun 30, 2024 | 208.08% |
| Mar 31, 2024 | -63.83% |
| Dec 31, 2023 | 204.55% |
| Sep 30, 2023 | -27.62% |
| Jun 30, 2023 | -198.02% |
| Mar 31, 2023 | 623.08% |
| Dec 31, 2022 | -18.28% |
| Sep 30, 2022 | 66.88% |
| Jun 30, 2022 | 119.84% |
| Mar 31, 2022 | -92.54% |
| Dec 31, 2021 | -129.43% |
| Sep 30, 2021 | -196.06% |